Business Wire: PQ Bypass Completes Enrollment in DETOUR2 Percutaneous Femoral-Popliteal Bypass Pivotal Study for Patients With Complex Peripheral Arterial Disease PQ Bypass Completes Enrollment in DETOUR2 Percutaneous Femoral-Popliteal Bypass Pivotal Study for Patients With Complex Peripheral Arterial Disease Healio: Endologix acquires PQ Bypass, developer of percutaneous femoral-popliteal bypass for PAD TCTMD: Endovascular Femoral Artery Bypass: First-in-Man Experience with a Novel, Percutaneous Approach to TASC D Lesions Endovascular Femoral Artery Bypass: First-in-Man Experience with a Novel, Percutaneous Approach to TASC D Lesions MILPITAS, Calif.--(BUSINESS WIRE)--PQ Bypass, an innovative medical device company pioneering advancements in the treatment of complex peripheral artery disease (PAD), announces enrollment of the ... Please provide your email address to receive an email when new articles are posted on . Endologix announced it completed the acquisition of PQ Bypass, a medical technology company that developed a ...
PharmiWeb: iPerf enrolls first patient in clinical trial of innovative dual-flow femoral arterial cannula for cardiopulmonary support
